Señales en vivo de IPA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 may 2024 @ 16:00):

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally...

Stats
Volumen de hoy	62 387.00
Volumen promedio	602 121
Capitalización de mercado	33.68M
EPS	$0 ( 2024-03-21 )
Próxima fecha de ganancias	( $-0.100 ) 2024-07-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.05
ATR14	$0.00800 (0.63%)

Insider Trading

Date	Person	Action	Amount	type
2008-12-12	Aisling Capital Ii Lp	Buy	861 826	Convertible 12% Note Due 2009
2008-12-12	Aisling Capital Ii Lp	Buy	10 412	Series D-1 Convertible Preferred Stock
2008-12-12	Aisling Capital Ii Lp	Buy	1	Warrant (right to buy)
2008-12-12	Aisling Capital Ii Lp	Buy	1	Warrant (right to buy)
2008-12-12	Aisling Capital Ii Lp	Sell	10 000	Series C-1 Convertible Preferred Stock

INSIDER POWER
0.00
Last 20 transactions
Buy: 4 917 425 \| Sell: 9 058 105

ImmunoPrecise Antibodies Correlación

10 Correlaciones Más Positivas
CBNK	0.964
ALRS	0.959
BWB	0.957
WTBA	0.956
UTHR	0.956
KNSA	0.955
HALO	0.952
SFST	0.951
AROW	0.951
WASH	0.95

10 Correlaciones Más Negativas
DUOL	-0.959
SVFAU	-0.957
LGACU	-0.957
APXI	-0.956
SVFA	-0.953
SCOB	-0.952
DSEY	-0.952
ALTR	-0.951
LGAC	-0.951
NVDA	-0.951

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

ImmunoPrecise Antibodies Finanzas

Annual	2022
Ingresos:	$20.67M
Beneficio Bruto:	$11.56M (55.95 %)
EPS:	$-1.070

FY	2022
Ingresos:	$20.67M
Beneficio Bruto:	$11.56M (55.95 %)
EPS:	$-1.070

FY	2022
Ingresos:	$19.36M
Beneficio Bruto:	$10.98M (56.72 %)
EPS:	$-0.850

FY	2021
Ingresos:	$17.91M
Beneficio Bruto:	$11.54M (64.41 %)
EPS:	$-0.450

Financial Reports:

No articles found.

ImmunoPrecise Antibodies

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.